Incorporating Patient Reported Outcomes and Real-World Evidence in Specialty Pharmacy Management to Improve Clinical Outcomes
Healthcare is experiencing a major paradigm shift, moving away from fee-for-service to pay-for-performance. With this paradigm shift, there have been many opinions on how to measure performance. Traditionally, healthcare quality was measured using biomarkers associated with improvement of disease state. These measures, while important, do not accurately provide the entire continuum of quality healthcare. Over the past several years, a greater focus is shifting to incorporate patient reported outcomes (PROs) into the overall measurement of healthcare performance. In addition, payers are interested in incorporating real-world evidence (RWE) in formulary management, which provides a clearer picture of the impact of a medication on patient outcomes.
This presentation will describe the differences between PROs, RWE, and other quality measures. Attendees will gain insight regarding how payers can leverage information from PROs and RWE to effectively review and manage formularies. Additionally, we will demonstrate how specialty pharmacies can be at the forefront generating real-world evidence and obtaining PROs and how they can apply this information to improve clinical practice.
Patty Taddei-Allen PharmD, MBA, Director, Outcomes Research, WellDyneRx
Nick Page PharmD, Chief Pharmacy Officer, WellDyneRx
Wednesday, March 6, 11:25 am to 12:15 pm - Track 3